Affiliation:
1. Division of Infectious Diseases, Department of Medicine , Icahn School of Medicine at Mount Sinai , New York , NY , USA
Abstract
Abstract
Human immunodeficiency virus type 1 (HIV-1) is a chronic disease that afflicts over 38 million people worldwide without a known cure. The advent of effective antiretroviral therapies (ART) has significantly decreased the morbidity and mortality associated with HIV-1 infection in people living with HIV-1 (PWH), thanks to durable virologic suppression. Despite this, people with HIV-1 experience chronic inflammation associated with co-morbidities. While no single known mechanism accounts for chronic inflammation, there is significant evidence to support the role of the NLRP3 inflammasome as a key driver. Numerous studies have demonstrated therapeutic impact of cannabinoids, including exerting modulatory effects on the NLRP3 inflammasome. Given the high rates of cannabinoid use in PWH, it is of great interest to understand the intersecting biology of the role of cannabinoids in HIV-1-associated inflammasome signaling. Here we describe the literature of chronic inflammation in people with HIV, the therapeutic impact of cannabinoids in PWH, endocannabinoids in inflammation, and HIV-1-associated inflammation. We describe a key interaction between cannabinoids, the NLRP3 inflammasome, and HIV-1 viral infection, which supports further investigation of the critical role of cannabinoids in HIV-1 infection and inflammasome signaling.
Funder
National Institute on Drug Abuse
National Institute of Allergy and Infectious Diseases
Reference125 articles.
1. WHO. HIV Fact Sheet, on World Health Organization; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/hiv-aids [Accessed 19 December 2022].
2. Swartz, TH, Dubyak, GR, Chen, BK. Purinergic receptors: key mediators of HIV-1 infection and inflammation. Front Immunol 2015;6:585. https://doi.org/10.3389/fimmu.2015.00585.
3. Freeman, TL, Swartz, TH. Purinergic receptors: elucidating the role of these immune mediators in HIV-1 fusion. Viruses 2020;12:290. https://doi.org/10.3390/v12030290.
4. Aberg, JA. Aging, inflammation, and HIV infection. Top Antivir Med 2012;20:101–5.
5. Sieg, SF, Shive, CL, Panigrahi, S, Freeman, ML. Probing the interface of HIV and inflammaging. Curr HIV AIDS Rep 2021;18:198–210. https://doi.org/10.1007/s11904-021-00547-0.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献